Holen Sie sich die Stockscreener-App
121.86
0.59%
-0.76
Schlusskurs vom Vortag:
$122.62
Offen:
$123.43
24-Stunden-Volumen:
7.89M
Relative Volume:
0.86
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.70%
1M Leistung:
-0.79%
6M Leistung:
+29.51%
1J Leistung:
+41.79%
1-Tages-Spanne:
$120.97
$124.91
1-Wochen-Bereich:
$120.97
$129.11
52-Wochen-Spanne:
$66.66
$132.09
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
121.90 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
327.05 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
664.19 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
667.15 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.95 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
594.78 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Jensen Has the Ball: Will Nvidia GTC AI Be a Market Buzzer-Beater? - Investing.com
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
Should You Consider Putting Money into the VanEck Biotech ETF (BBH)? - Bitget
JPMorgan (AMJB) prices callable contingent‑interest notes linked to SCZ/XBI/KRE - Stock Titan
State Street SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofPTC Therapeutics (NASDAQ:PTCT) - Benzinga
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares? - Bitget
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Moderna, Mexico Partner To Boost Local Vaccine ProductionModerna (NASDAQ:MRNA) - Benzinga
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors - Defense World
These Three Biotechs Have the Right Mix as the Industry Gains - TheStreet Pro
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Biotech ETF (XBI) Hits New 52-Week High - TradingView
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg
Stock Market Today: Dow gains 250 points, S&P 500 and Nasdaq advance after Trump’s Greenland pivot boosts risk appetite - MarketWatch
Moderna Stock Explodes To New 52-Week High: What's Driving The Action? - Benzinga
2025 ETF Wrap-Up And What To Expect In 2026 - Seeking Alpha
Should you invest in the State Street SPDR S&P Biotech ETF (XBI)? - MSN
U.S. Biotech Rebound in 2026: IPOs, Deals & Policy Clarity Drive OptimismNews and Statistics - IndexBox
Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84% - Intellectia AI
US Biotech Share Sales Deliver Biggest First Week Since 2021 - Bloomberg
‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Equity Markets Rally, Commodities Decline as ETF Investors Optimize Portfolios for 2026 - Bitget
Equities Surge, Commodities Sink As ETF Investors Plan 2026Vanguard S&P 500 ETF (ARCA:VOO) - Benzinga
As Artificial Intelligence Stocks Surge in Value, Health Care ETFs Take Center Stage for Growth - Bitget
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Biotech and pharma stocks tumble as investors race into energy - MSN
Biotech and Pharma Stocks Tumble as Investors Race into Energy - Barron's
Biotech: Time For A Pause To Start 2026 - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - sharewise.com
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood - Seeking Alpha
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - MSN
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Look What I Found While Bargain Hunting in the Biotech Sector - TheStreet Pro
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026 - Benzinga
If You Invested $100 In State Street SPDR S&P Biotech ETF Stock 20 Years Ago, You Would Have This Much Today - Benzinga
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
Why Is Trinity Biotech Stock Soaring Tuesday? - Benzinga
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):